Ping Tang, B.Med., Ph.D.

Ping Tang, B.Med., Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 626
Rochester, NY 14642

Office: (585) 275-6640
Fax: (585) 273-3637

Research Bio

Dr. Tang's Ph.D. research at the University of Texas MD Anderson Cancer Center involved tumor necrosis factor signal transduction and protein processing. From 1995-98 she served as a postdoctoral fellow, studying growth inhibition of glioma cells by antisense TGF-alpha. Since her residency at North Shore and her surgical pathology fellowship at Yale, she has focused on early breast carcinogenesis.



At Rochester, Dr. Tang was the recipient of an Empire Clinical Research Investigator Program (ECRIP) award to fund a study of molecular markers that may predict a subgroup of ductal carcinoma in situ (DCIS) with high risk of progression to invasive ductal carcinoma (IDC). DCIS is a heterogeneous group of lesions that accounts over 20% of breast carcinoma diagnosed annually which has a 14-53% chance of progression to IDC over a 10-year period.

She is currently working to identify a group of biomarkers that will predict a subset of breast tumors with a high risk of bone metastasis. She is using immunocytochemistry, a common and relatively inexpensive form of analysis, in the hope that her findings may be easily translated into clinical practice, allowing more aggressive treatment of tumors with greater risk of metastasis.

Awards & Honors (Local)

Sowell-Huggins award from The University of Texas MD Anderson Cancer Center Graduate School of Biomedical Sciences in Houston. 1995
A two-year fellowship from Boehringer Ingelheim Foundation of Germany. 1988
The First National Conference for outstanding young and middle age basic scientists in Beijing, PR China 1986

Recent Journal Articles

Showing the 5 most recent journal articles. 40 available »

2014 Mar 12
Zhang Z, Wang J, Skinner KA, Shayne M, Hajdu SI, Hong B, Hicks DG, Tang P. "Pathologic features and clinical outcomes of breast cancer according to the levels of expression of estrogen receptor." Histopathology.. 2014 Mar 12; Epub 2014 Mar 12.
2014 Feb 24
Hoang LL, Tang P, Hicks DG, Chen H, Yang Q, Haas TS, Bremer RE, Tacha D. "A New Rabbit Monoclonal E-Cadherin Antibody [EP700Y] Shows Higher Sensitivity Than Mouse Monoclonal E-Cadherin [HECD-1] Antibody in Breast Ductal Carcinomas and Does Not Stain Breast Lobular Carcinomas." Applied immunohistochemistry & molecular morphology : AIMM. 2014 Feb 24; Epub 2014 Feb 24.
2012 Apr
Subik K, Shu L, Wu C, Liang Q, Hicks D, Boyce B, Schiffhauer L, Chen D, Chen C, Tang P, Xing L. "The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis." Bone.. 2012 Apr; 50(4):813-23. Epub 2012 Jan 11.
2011 Feb
Tang P, Wei B, Yang WJ, Liu YS, Bu H. "[Prognostic factors of breast cancer]." Zhonghua bing li xue za zhi Chinese journal of pathology. 2011 Feb; 40(2):73-6.
2010 Nov
Tang P, Wang J, Hicks DG, Wang X, Schiffhauer L, McMahon L, Yang Q, Shayne M, Huston A, Skinner KA, Griggs J, Lyman G. "A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer." Cancer investigation. 2010 Nov; 28(9):978-82.

Current Appointments

Professor - Department of Pathology and Laboratory Medicine (SMD) - Primary

Specialties

Clinical Pathology/Laboratory Medicine - American Board of Pathology

Education

PhD | Cancer Biology | Univ Texas M D Anderson Hosp1995
MD | Medicine | China-West China Univ Med Sci, Chengdu1983

Post-Doctoral Training & Residency

Fellowship in Surgical Pathology at Yale University -New Haven Hospital07/01/2002 - 06/30/2003
Residency in Pathology at North Shore University Hospital07/01/1998 - 06/30/2002
Fellowship at University of Texas M D Anderson Cancer Center07/01/1995 - 06/30/1998